{"id":202825,"date":"2026-04-10T11:28:25","date_gmt":"2026-04-10T10:28:25","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/"},"modified":"2026-04-10T11:28:25","modified_gmt":"2026-04-10T10:28:25","slug":"los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/","title":{"rendered":"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012"},"content":{"rendered":"

El 11 de abril se conmemora el D\u00eda Mundial del P\u00e1rkinson. La enfermedad ya es la segunda patolog\u00eda neurodegenerativa m\u00e1s frecuente en el mundo y la que mayor incremento est\u00e1 experimentando en t\u00e9rminos de prevalencia, discapacidad y mortalidad. En Espa\u00f1a, seg\u00fan datos de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN), afecta ya a m\u00e1s de 200 000 personas, con unos 10 000 nuevos diagn\u00f3sticos cada a\u00f1o.<\/p>\n

Actualmente, Espa\u00f1a es el noveno con m\u00e1s casos de p\u00e1rkinson en el mundo a pesar de ser el 31\u00ba m\u00e1s poblado. Las previsiones epidemiol\u00f3gicas se\u00f1alan que en 2050, Espa\u00f1a ser\u00e1 el pa\u00eds con mayor prevalencia por habitante, con cifras cercanas a los 850 casos por cada 100 000 personas.<\/p>\n

\u00c1lvaro S\u00e1nchez Ferro, coordinador del Grupo de Estudio de Trastornos del Movimiento de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN), destaca un factor principal que ocasiona el aumento: el envejecimiento de la poblaci\u00f3n.\u00a0Sin embargo, existen otras causas gen\u00e9ticas y ambientales: \u201cAspectos como la exposici\u00f3n a pesticidas y contaminantes, el sedentarismo o el mal control de factores vasculares pueden tener mucha influencia en el desarrollo de la enfermedad, lo que muestra la importancia de la prevenci\u00f3n basada en h\u00e1bitos de vida cerebrosaludables\u201d.<\/p>\n

<\/p>\n

El previsible aumento de casos en las pr\u00f3ximas d\u00e9cadas tendr\u00e1 un impacto muy significativo en los sistemas sanitarios<\/p>\n

Dr. \u00c1lvaro S\u00e1nchez Ferro, Sociedad Espa\u00f1ola de Neurolog\u00eda
\n<\/p>\n

La enfermedad de Parkinson suele manifestarse en torno a los 60 a\u00f1os y afecta con una frecuencia ligeramente mayor a los hombres. Su prevalencia aumenta con la edad: del 2\u202f% de la poblaci\u00f3n en mayores de 65 a\u00f1os asciende hasta el 4 % en mayores de 80 a\u00f1os. Sin embargo, no se trata de una enfermedad exclusiva de las personas mayores: un 15 % de los pacientes presentan s\u00edntomas de inicio temprano, antes de los 45 a\u00f1os. Estos casos tienen una mayor probabilidad de tener un componente gen\u00e9tico o familiar en comparaci\u00f3n con las formas de inicio tard\u00edo.<\/p>\n

Aunque cada vez se identifican m\u00e1s variantes gen\u00e9ticas asociadas al p\u00e1rkinson, menos del 10 % de los casos son claramente hereditarios. \u201cEl previsible aumento de casos en las pr\u00f3ximas d\u00e9cadas tendr\u00e1 un impacto muy significativo en los sistemas sanitarios. Por ello, es prioritario no solo impulsar la investigaci\u00f3n de tratamientos m\u00e1s eficaces, sino tambi\u00e9n mejorar la planificaci\u00f3n de recursos y fomentar estrategias de prevenci\u00f3n basadas en h\u00e1bitos de vida saludables\u201d, dice el experto.<\/p>\n


\n \"Un
\n <\/a><\/p>\n

<\/a><\/p>\n

Un an\u00e1lisis gen\u00e9tico de sangre para una detecci\u00f3n precoz del p\u00e1rkinson<\/h3>\n

<\/p>\n


\n SINC
\n <\/a> <\/p>\n

<\/a><\/p>\n

La depresi\u00f3n, entre los primeros s\u00edntomas\u00a0<\/h2>\n

El p\u00e1rkinson se caracteriza por la degeneraci\u00f3n progresiva de las neuronas encargadas de producir dopamina. Al disminuirse este neurotransmisor, los circuitos cerebrales implicados en el control del movimiento dejan de funcionar de forma correcta. Algunos de los s\u00edntomas motores m\u00e1s caracter\u00edsticos son el temblor en reposo, rigidez, lentitud extrema de los movimientos voluntarios o la inestabilidad postural.\u00a0<\/p>\n

Algunos de los\u00a0s\u00edntomas motores\u00a0m\u00e1s caracter\u00edsticos son el temblor en reposo, rigidez, lentitud extrema\u00a0<\/p>\n

Sin embargo, existe una serie de s\u00edntomas no motores, como trastornos del sue\u00f1o, depresi\u00f3n o deterioro cognitivo, que a veces preceden incluso a\u00f1os al inicio de los s\u00edntomas motores. De hecho, hasta en un 30\u202f% de los casos, la depresi\u00f3n puede ser una de las primeras manifestaciones cl\u00ednicas de la enfermedad.<\/p>\n

Seg\u00fan la SEN, esta heterogeneidad cl\u00ednica de la enfermedad y el hecho de que su diagn\u00f3stico contin\u00faa siendo fundamentalmente cl\u00ednico son las principales razones por la falta de diagn\u00f3stico en fases iniciales de la enfermedad. Se estima que en Espa\u00f1a existe un retraso medio de entre uno y tres a\u00f1os desde la aparici\u00f3n de los primeros s\u00edntomas hasta el diagn\u00f3stico de la enfermedad.<\/p>\n

La mayor\u00eda de los tratamientos actuales para la enfermedad son sintom\u00e1ticos. Los esfuerzos actuales est\u00e1n dirigidos al desarrollo de terapias modificadoras de la enfermedad, como la terapia g\u00e9nica, la inmunoterapia y las terapias celulares. S\u00e1nchez Ferro destaca que existe un ensayo fase 3 con un f\u00e1rmaco que elimina una de las prote\u00ednas que se acumulan en la enfermedad de Parkinson.\u00a0<\/p>\n

Seg\u00fan explica, Jap\u00f3n ha autorizado de forma condicional el primer tratamiento basado en c\u00e9lulas madre. \u201cAunque todav\u00eda es necesario confirmar la eficacia, durabilidad del efecto y el perfil de seguridad de estas estrategias, en general reflejan que estamos ante un cambio significativo en el abordaje terap\u00e9utico del p\u00e1rkinson, al permitir ir a los mecanismos que producen la enfermedad en lugar de limitarse al control sintom\u00e1tico\u201d, concluye el experto.<\/p>","protected":false},"excerpt":{"rendered":"

El 11 de abril se conmemora el D\u00eda Mundial del P\u00e1rkinson. La enfermedad ya es la segunda patolog\u00eda neurodegenerativa m\u00e1s frecuente en el mundo y la que mayor incremento est\u00e1 experimentando en t\u00e9rminos de prevalencia, discapacidad y mortalidad. En Espa\u00f1a, seg\u00fan datos de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN), afecta ya a m\u00e1s de 200 […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-202825","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"\nLos diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012 - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012\" \/>\n<meta property=\"og:description\" content=\"El 11 de abril se conmemora el D\u00eda Mundial del P\u00e1rkinson. La enfermedad ya es la segunda patolog\u00eda neurodegenerativa m\u00e1s frecuente en el mundo y la que mayor incremento est\u00e1 experimentando en t\u00e9rminos de prevalencia, discapacidad y mortalidad. En Espa\u00f1a, seg\u00fan datos de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN), afecta ya a m\u00e1s de 200 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-10T10:28:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012\",\"datePublished\":\"2026-04-10T10:28:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/\"},\"wordCount\":812,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/\",\"name\":\"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012 - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\",\"datePublished\":\"2026-04-10T10:28:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\",\"contentUrl\":\"https:\\\/\\\/www.agenciasinc.es\\\/bundles\\\/app\\\/images\\\/quotebefore.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012 - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/","og_locale":"es_ES","og_type":"article","og_title":"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012","og_description":"El 11 de abril se conmemora el D\u00eda Mundial del P\u00e1rkinson. La enfermedad ya es la segunda patolog\u00eda neurodegenerativa m\u00e1s frecuente en el mundo y la que mayor incremento est\u00e1 experimentando en t\u00e9rminos de prevalencia, discapacidad y mortalidad. En Espa\u00f1a, seg\u00fan datos de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN), afecta ya a m\u00e1s de 200 […]","og_url":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/","og_site_name":"bip4ex","article_published_time":"2026-04-10T10:28:25+00:00","og_image":[{"url":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012","datePublished":"2026-04-10T10:28:25+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/"},"wordCount":812,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/","url":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/","name":"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012 - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","datePublished":"2026-04-10T10:28:25+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/#primaryimage","url":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png","contentUrl":"https:\/\/www.agenciasinc.es\/bundles\/app\/images\/quotebefore.png"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/los-diagnosticos-de-parkinson-en-espana-se-duplican-desde-2012\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Los diagn\u00f3sticos de p\u00e1rkinson en Espa\u00f1a se duplican desde 2012"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/202825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=202825"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/202825\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=202825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=202825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=202825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}